BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35522392)

  • 21. Ectopic primary olfactory neuroblastoma of the maxillary sinus.
    Holmes M; Su SY; Bell D
    Ann Diagn Pathol; 2016 Jun; 22():45-8. PubMed ID: 27180059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine neoplasms of the head and neck and olfactory neuroblastoma. Diagnosis and classification.
    Uccella S; Ottini G; Facco C; Maragliano R; Asioli S; Sessa F; La Rosa S
    Pathologica; 2017 Mar; 109(1):14-30. PubMed ID: 28635990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytological diagnosis of olfactory neuroblastoma at metastatic sites, with emphasis on role of insulinoma-associated protein 1 immunocytochemistry.
    Roy D; Sriram S; Kakkar A; Kumar R; Kaur K; Jain D; Sharma A; Thakar A
    Diagn Cytopathol; 2023 Feb; 51(2):146-152. PubMed ID: 36369994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Olfactory neuroblastoma with unusual structures: a clinical pathologic study].
    Yao Q; Yue CL; Lü ZC; Han YD; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):163-8. PubMed ID: 19575850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma.
    Bellizzi AM; Bourne TD; Mills SE; Stelow EB
    Am J Clin Pathol; 2008 Mar; 129(3):367-76. PubMed ID: 18285258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactory neuroblastoma and other round cell lesions of the sinonasal region.
    Devaney K; Wenig BM; Abbondanzo SL
    Mod Pathol; 1996 Jun; 9(6):658-63. PubMed ID: 8782204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells.
    Zunitch MJ; Fisch AS; Lin B; Barrios-Camacho CM; Faquin WC; Tachie-Baffour Y; Louie JD; Jang W; Curry WT; Gray ST; Lin DT; Schwob JE; Holbrook EH
    Mod Pathol; 2023 May; 36(5):100122. PubMed ID: 36841178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
    Chiesa-Vottero A
    Int J Gynecol Pathol; 2020 Mar; 39(2):170-177. PubMed ID: 32045390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lobular to Lobule: Metastatic Breast Carcinoma to Olfactory Neuroblastoma.
    Swimley KM; Di Palma S; Thompson LDR
    Head Neck Pathol; 2021 Jun; 15(2):642-648. PubMed ID: 32661671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable
    Lazo de la Vega L; McHugh JB; Cani AK; Kunder K; Walocko FM; Liu CJ; Hovelson DH; Robinson D; Chinnaiyan AM; Tomlins SA; Harms PW
    Mol Cancer Res; 2017 Nov; 15(11):1551-1557. PubMed ID: 28775129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
    Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
    J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
    Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
    Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
    Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
    Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract.
    Bourne TD; Bellizzi AM; Stelow EB; Loy AH; Levine PA; Wick MR; Mills SE
    Am J Clin Pathol; 2008 Aug; 130(2):213-8. PubMed ID: 18628089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
    Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
    Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olfactory Neuroblastoma with Divergent Differentiation: An Unusual Histologic Finding in a Rare Tumor.
    Meyer C; Hamersley ERS; Manosalva RE; Torske K; McIntyre N; Mitchell A
    Head Neck Pathol; 2017 Dec; 11(4):531-536. PubMed ID: 28168398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).
    Carney ME; O'Reilly RC; Sholevar B; Buiakova OI; Lowry LD; Keane WM; Margolis FL; Rothstein JL
    J Neurooncol; 1995 Oct; 26(1):35-43. PubMed ID: 8583243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.
    Mehta GU; Raza SM; Su SY; Hanna EY; DeMonte F
    J Neurooncol; 2020 Dec; 150(3):367-375. PubMed ID: 32424573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of EWS/FLI1 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing's sarcoma family.
    Kumar S; Perlman E; Pack S; Davis M; Zhang H; Meltzer P; Tsokos M
    Hum Pathol; 1999 Nov; 30(11):1356-60. PubMed ID: 10571517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on pathological features and diagnosis, differential diagnosis of olfactory neuroblastoma].
    Liu HG; Zhang SZ; He CY
    Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):432-6. PubMed ID: 14633455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.